NDC 0173-0521

SEREVENT DISKUS

Salmeterol Xinafoate

SEREVENT DISKUS is a Oral; Respiratory (inhalation) Powder, Metered in the Human Prescription Drug category. It is labeled and distributed by Glaxosmithkline Llc. The primary component is Salmeterol Xinafoate.

Product ID0173-0521_0b0ff537-8ccc-48c1-af9c-750b0969af53
NDC0173-0521
Product TypeHuman Prescription Drug
Proprietary NameSEREVENT DISKUS
Generic NameSalmeterol Xinafoate
Dosage FormPowder, Metered
Route of AdministrationORAL; RESPIRATORY (INHALATION)
Marketing Start Date1997-11-25
Marketing CategoryNDA / NDA
Application NumberNDA020692
Labeler NameGlaxoSmithKline LLC
Substance NameSALMETEROL XINAFOATE
Active Ingredient Strength50 ug/1
Pharm ClassesAdrenergic beta2-Agonists [MoA],beta2-Adrenergic Agonist [EPC]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 0173-0521-00

1 INHALER in 1 CARTON (0173-0521-00) > 60 POWDER, METERED in 1 INHALER
Marketing Start Date1997-11-25
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0173-0521-00 [00173052100]

SEREVENT DISKUS POWDER, METERED
Marketing CategoryNDA
Application NumberNDA020692
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1997-11-25

Drug Details

Active Ingredients

IngredientStrength
SALMETEROL XINAFOATE50 ug/1

OpenFDA Data

SPL SET ID:12d9728e-6b5c-4aee-bfb0-745e542ed2e4
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 866047
  • 866044
  • 866048
  • 866049
  • Pharmacological Class

    • Adrenergic beta2-Agonists [MoA]
    • beta2-Adrenergic Agonist [EPC]

    NDC Crossover Matching brand name "SEREVENT DISKUS" or generic name "Salmeterol Xinafoate"

    NDCBrand NameGeneric Name
    0173-0520SEREVENTsalmeterol xinafoate
    0173-0521SEREVENTsalmeterol xinafoate
    68258-8961SEREVENTsalmeterol xinafoate

    Trademark Results [SEREVENT]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    SEREVENT
    SEREVENT
    73694169 1628891 Live/Registered
    GLAXO GROUP LIMITED
    1987-11-09

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.